Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type
Description
A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers. MeSH
Hierarchy View
Subtype Terms (14)
Histiocytic Disorders, Malignant
1 approved drug
Leukemia
577 drugs (260 approved, 317 experimental)
Lymphoma
1032 drugs (407 approved, 625 experimental)
Neoplasms, Connective and Soft Tissue
16 drugs (12 approved, 4 experimental)
Neoplasms, Germ Cell and Embryonal
136 drugs (88 approved, 48 experimental)
Neoplasms, Glandular and Epithelial
31 drugs (18 approved, 13 experimental)
Neoplasms, Nerve Tissue
20 drugs (10 approved, 10 experimental)
Neoplasms, Plasma Cell
53 drugs (39 approved, 14 experimental)
Phase 4 Indicated Drugs (2)
Phase 2 Indicated Drugs (19)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
